TRT in treatment for hypogonadism and prostate cancer risk

Discussions about the pros and cons of testosterone replacement therapy (TRT) in relation to (a) stimulating risk for prostate cancer in men who have not been diagnosed and (b) recurrence of prostate cancer among men who have been diagnosed and treated often aren’t entirely clear about a very key factor. … READ MORE …

The efficacy and safety of TRT in men with treated and untreated prostate cancer

As we have mentioned frequently before, the use of testosterone replacement therapy (TRT) in men diagnosed with and/or treated for prostate cancer has been highly controversial, and the data supporting a role for TRT in such patients has been limited. … READ MORE …

Testosterone treatment in aging men with hypogonadism

Testosterone levels tend to fall in most men as we age. This is hardly new information! An article this week in the New England Journal of Medicine suggests that treatment with testosterone gels is appropriate for aging men with low testosterone levels (hypogonadism). … READ MORE …

TRT and prostate cancer risk in hypogonadal men

A new paper in the Journal of Urology provides data from European males with clinically low levels of serum testosterone indicating that, in these patients, testosterone replacement therapy (TRT) was not associated with any increase in risk for a diagnosis of prostate cancer. … READ MORE …

Supplemental testosterone therapy in men treated for prostate cancer

The role of supplemental testosterone therapy in men previously treated for prostate cancer has long been a controversial issue, and the number of patients actually studied for the effects of such therapy (good and bad) is really quite small — at about 600 worldwide. … READ MORE …

TRT after radical prostatectomy for localized prostate cancer in hypogonadal males

A new paper just published in the Journal of Urology addresses (again) the controversial issue of whether the use of testosterone replacement therapy (TRT) is appropriate as a management strategy after first-line treatment for hypogonadal patients. … READ MORE …

Testosterone replacement therapy in men with low serum T and untreated prostate cancer

An article in the May issue of BJU International has proposed establishment of an international data registry as being “the quickest way” to establish basic data on the risks related to testosterone replacement therapy in men with untreated prostate cancer. … READ MORE …